Natera Launches TEODOR Trial in Partnership with ABCSG to Advance Personalized Breast Cancer Treatment
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2, […]
Interventional Radiology Market: Size, Growth, and Leading Companies Driving Innovation
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic
Physical Therapy Market Growth and Leading Companies Driving Innovation
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025
Unlocking DNA: How the Direct-To-Consumer Genetic Testing Market is Redefining Healthcare – A Glimpse into China’s Rising Trends
The Direct-To-Consumer Genetic Testing Market is witnessing a global transformation, driven by the growing consumer demand for personalized healthcare insights.
Canadian Digital Health Market Sees Steady Growth in 2025
The global digital health market is witnessing a steady rise and much of it is driven by the increasing number
North America Takes the Lead in Healthcare CRO Market
In 2025, North America emerged as the clear frontrunner in the healthcare Contract Research Organization (CRO) market and it’s easy
Virocell and Avencell Team Up to Advance Breakthrough CAR-T Therapies
Powering the Future of Cell and Gene Therapy Virocell Biologics, a leading name in vector manufacturing for cell and gene
Pahr Therapeutics Secures $14M to Advance New Treatments for Pulmonary Arterial Hypertension
A Big Leap Forward in PAH Care Pahr Therapeutics Inc. has raised $14 million in seed funding to accelerate its
Bristol Myers Squibb & Bain Capital Launch a Bold New Biotech Venture to Tackle Autoimmune Diseases
Reimagining Immunology, Together In a groundbreaking partnership, Bristol Myers Squibb (BMS) and Bain Capital have come together to launch a
Genethon Launches Promising New Trial in Europe for Duchenne Muscular Dystrophy Big Step Forward for Gene Therapy
Genethon, a global leader in gene therapy for rare genetic diseases, has received the green light from the UK and